In other drug development news, pharmaceutical company Cosmo said its placebo-controlled phase II trial of rifamycin 1% ...

For the first time, a joint guideline from the American Gastroenterological Association (AGA) and American Association for ...

PPAR agonists, antigen-specific immune tolerance therapies and IBAT inhibitors lead the PBC pipeline as companies target patients with an inadequate response to UDCA.Dublin, Oct. (GLOBE NEWSWIRE) -- ...

For the first time, a joint guideline from the American Gastroenterological Association (AGA) and American Association for ...

US gastroenterology and liver disease associations issued joint guidelines on diagnosing and treating primary biliary ...

Saroglitazar shows promise as a second-line treatment for primary biliary cholangitis in US and non-US patient groups.

Researchers report that Klebsiella pneumoniae enriched in the guts of primary biliary cholangitis patients can translocate to the liver and drive the inflammatory and metabolic disturbances ...

The Russian Ministry of Health has added primary biliary cholangitis, a chronic autoimmune liver disease, to the list of orphan diseases. This is stated in a departmental document, which was reviewed ...

Have you ever been told during a health checkup that your liver function values are high?Even if it says "re-examination required," you might think, "I don't feel particularly unwell, so I'm probably ...

Patients with primary sclerosing cholangitis and moderate to severe pruritus reported significantly lower cholestatic ...

Patients with concurrent PBC and osteoporosis do not have an increased risk of major bone fracture vs patients with ...